（原标题：AI赋能手术机器人 行业发展驶入快车道丨人工智能AI瞭望台） AI+医疗赛道正驶入发展快车道。 人工智能（AI）正以前所未有的速度渗透到普通人生活的方方面面，从金融交易到交通出行，从社交媒体互动到运动健身指导，背后都有AI的身 影。而在医疗健康领域，AI的应用也逐渐走进诊疗一线。当前，AI凭借其强大的数据分析、图像识别以及智能决策能力，在疾病诊断、治疗方案 制定、手术辅助乃至医疗资源管理等诸多环节展现出巨大潜力，为解决医疗行业面临的效率低下、误诊漏诊风险、医疗资源分配不均等难题提供 了创新路径。 AI赋能心血管手术机器人 一位技术人员在手术室外操控机器主端，通过语音命令，远程操纵手术室内的从端机械臂，精准完成引导丝的推进、旋转和回撤，导引导管的调 整、球囊的扩张、支架的放置等血管介入手术全流程的器械使用与操作。这是记者在由AI驱动的全自动血管介入手术机器人发布现场看到的场 景。这台备受关注的设备，由深圳睿心智能医疗科技有限公司设计研发。 睿心医疗于2017年在深圳创立，3位联合创始人均为美国知名大学博士，且在美国医疗行业拥有多年工作经验。目前，公司已陆续完成5轮融资， 投资方包括国投创新、经纬创投、 ...

一位技术人员在手术室外操控机器主端，通过语音命令，远程操纵手术室内的从端机械臂，精准完成引导丝的推进、旋转和回撤，导引导管的调整、球囊的 扩张、支架的放置等血管介入手术全流程的器械使用与操作。这是记者在由AI驱动的全自动血管介入手术机器人发布现场看到的场景。这台备受关注的设 备，由深圳睿心智能医疗科技有限公司设计研发。 睿心医疗于2017年在深圳创立，3位联合创始人均为美国知名大学博士，且在美国医疗行业拥有多年工作经验。目前，公司已陆续完成5轮融资，投资方包括 国投创新、经纬创投、腾讯等。 AI+医疗赛道正驶入发展快车道。 人工智能（AI）正以前所未有的速度渗透到普通人生活的方方面面，从金融交易到交通出行，从社交媒体互动到运动健身指导，背后都有AI的身影。而在医疗 健康领域，AI的应用也逐渐走进诊疗一线。当前，AI凭借其强大的数据分析、图像识别以及智能决策能力，在疾病诊断、治疗方案制定、手术辅助乃至医疗资 源管理等诸多环节展现出巨大潜力，为解决医疗行业面临的效率低下、误诊漏诊风险、医疗资源分配不均等难题提供了创新路径。 AI赋能心血管手术机器人 "传统的心血管手术中，医生需要穿戴厚重的铅衣，在强辐射的环境下工 ...

Group 1 - The Shanghai Composite Index reached a nearly 10-year high of 3745.94 points, with A-share market capitalization surpassing 100 trillion yuan for the first time [1] - The Robot ETF (562500) rose by 1.98%, with a maximum intraday increase of 2.81%, indicating its potential as a "satellite" for sustained market breakthroughs [1] - The liquidity in the market was active, with a turnover rate of 6.92% and a transaction amount of 1.203 billion yuan, reflecting strong market engagement [1] Group 2 - Minsheng Securities highlighted the long-term potential of robots, with Musk aiming to produce hundreds of Optimus V3 prototypes this year and reaching a million units in five years [2] - The Robot ETF (562500) is the only robot-themed ETF in the market with a scale exceeding 10 billion yuan, covering various segments including humanoid robots, industrial robots, and service robots [2] - Yushutec has initiated its listing guidance, accelerating the securitization process of leading domestic humanoid robot manufacturers, which is becoming a new catalyst for the sector [2]

Core Viewpoint - Ruixin Medical is committed to developing an all-automatic AI vascular interventional surgical robot to enhance early diagnosis and precise treatment of cardiovascular diseases, aiming to create a closed-loop diagnostic and treatment system [1][3]. Company Developments - The all-automatic AI vascular interventional surgical robot is expected to complete animal surgeries using AI automation in the second half of this year, following prototype production and simulation experiments [3]. - The robot aims to assist in simple and repetitive surgical procedures under the supervision of doctors, while providing enhanced support for more challenging surgeries [3][4]. Industry Challenges - The cardiovascular treatment field faces three main challenges: heavy physical burden on doctors due to lead aprons, variability in manual operations leading to training difficulties for younger doctors, and uneven distribution of medical resources across the country [3][4]. Technological Integration - Ruixin Medical's robot integrates a tri-party collaboration among doctors, intelligent systems, and execution terminals, allowing for natural language interaction and automated surgical operations [4]. - The short-term goals include reducing radiation exposure, alleviating the burden of lead aprons, lowering repetitive tasks, shortening training periods, standardizing surgical quality, and supporting remote medical services [4]. Regulatory Environment - The launch of the robot coincides with the National Medical Products Administration's new measures to support high-end medical device innovation, marking a significant step towards the "fully automatic" intelligent era in vascular intervention [5]. Expert Insights - Experts agree that the integration of AI and fully automatic vascular interventional robots represents a major trend for the future, emphasizing the importance of overcoming challenges to lead in this innovative field [5].